Melekoglu Asli Nuriye, Baspinar Osman
1 Department of Paediatrics, Division of Neonatology, Malatya Training and Research Hospital, Malatya, Turkey.
2 Department of Paediatrics, Division of Paediatric Cardiology, Faculty of Medicine, The University of Gaziantep, Gaziantep, Turkey.
J Int Med Res. 2019 Feb;47(2):615-625. doi: 10.1177/0300060518806111. Epub 2018 Oct 30.
Percutaneous cardiac catheterization has been used as a diagnostic tool and as a therapeutic option in neonates with congenital heart disease (CHD). This study aimed to evaluate the procedural and short-term follow-up data of newborns who underwent cardiac catheterization procedures.
This retrospective study reviewed demographic, diagnostic and clinical data from the medical records of newborns who underwent percutaneous transcatheter interventions to treat CHD.
Forty-six newborns were included in the study. The median gestational week and weight were 35.0 weeks and 2723 g, respectively. The median time to the procedure was 7.6 days. Aortic and pulmonary balloon valvuloplasty, ductal stenting, atrial balloon/blade septostomy and coronary fistula embolization procedures were used. The overall success rate was 73.9% (34 of 46 patients) with a complication rate of 28.3% (13 of 46 patients). Eleven patients (23.9%) underwent reinterventions after initial catheterization. Five patients (10.9%) died in the first 48 h after their procedures.
Interventional cardiological procedures applied during the neonatal period provide alternative life-saving methods to surgery, especially in developing countries where surgical outcomes are poor and newborn mortality rates are high.
经皮心脏导管插入术已被用作先天性心脏病(CHD)新生儿的诊断工具和治疗选择。本研究旨在评估接受心脏导管插入术的新生儿的手术过程及短期随访数据。
这项回顾性研究回顾了接受经皮导管介入治疗CHD的新生儿病历中的人口统计学、诊断和临床数据。
46名新生儿纳入研究。中位孕周和体重分别为35.0周和2723克。手术的中位时间为7.6天。采用了主动脉和肺动脉球囊瓣膜成形术、导管支架置入术、心房球囊/刀片造口术和冠状动脉瘘栓塞术。总体成功率为73.9%(46例患者中的34例),并发症发生率为28.3%(46例患者中的13例)。11例患者(23.9%)在初次导管插入术后接受了再次干预。5例患者(10.9%)在手术后的头48小时内死亡。
新生儿期应用的介入性心脏病学手术为手术提供了挽救生命的替代方法,尤其是在手术效果差且新生儿死亡率高的发展中国家。